Over 10,000 results
Page 3 of 100
8-K
EX-99.2
cz6p6
6 Jun 24
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
11:16am
N-CSR
no0qm4arsk34h4
6 Jun 24
Certified annual shareholder report (management investment company)
10:08am
424B3
53b9ty1p gi
5 Jun 24
Prospectus supplement
4:08pm
S-1/A
mvh 6wx7m
5 Jun 24
IPO registration (amended)
6:04am
8-K
EX-99.2
ost0uwb gw
5 Jun 24
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
6:00am
8-K
EX-99.1
y94bp9 nm9gf8
5 Jun 24
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
6:00am
PRER14A
b0s608d d42fs0jpfn0l
4 Jun 24
Preliminary revised proxy
8:30pm
6-K
ybrdo
4 Jun 24
Current report (foreign)
4:23pm
SC TO-I
EX-99
2xp8a72 k8w
3 Jun 24
Issuer tender offer statement
5:10pm
8-K
EX-99.1
x3h3j
3 Jun 24
Regulation FD Disclosure
4:08pm
6-K
EX-99.1
1hgvv45uh ocnb
3 Jun 24
Current report (foreign)
4:05pm
425
EX-99.1
idwn2ijp4 d36fohk6
3 Jun 24
Business combination disclosure
8:50am
8-K
EX-99.1
9yap49ti22h2jyl ce0
3 Jun 24
Regulation FD Disclosure
8:45am